Citation Impact
Citing Papers
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Epidemiology and causes of preterm birth
2008 Standout
Outbreak of Cutaneous Leishmaniasis in Northern Israel
2003
Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate Alone
1993
Occurrence of Leishmania donovani parasitemia in plasma of infected hamsters
2001
Leishmaniasis
2018 Standout
Ribosomes ofLeishmania are a target for the aminoglycosides
1995
Burden of disease from inadequate water, sanitation and hygiene for selected adverse health outcomes: An updated analysis with a focus on low- and middle-income countries
2019 Standout
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
2006
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
A policy for leishmaniasis with respect to the prevention and control of drug resistance
2001
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial
2008 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
2000
Synthesis of spherical silver nanoparticles by digestive ripening, stabilization with various agents, and their 3-D and 2-D superlattice formation
2004
Practical progress and new drugs for changing patterns of leishmaniasis
1993
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in Bihar
1998
How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence
2001 Standout
Paromomycin
2008
Cutaneous leishmaniasis
2007 Standout
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
2003
Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica
1994
The Theory of Planned Behavior: A Review of its Applications to Health-Related Behaviors
1996 Standout
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
2007 Standout
Challenges and new discoveries in the treatment of leishmaniasis
2004
Efficacy Comparison between Povidone Iodine 2.5% and Tetracycline 1% in Prevention of Ophthalmia Neonatorum
2011
Efficacy of the Theory of Planned Behaviour: A meta‐analytic review
2001 Standout
Scientific basis for the content of routine antenatal care
1997
Combination therapy for visceral leishmaniasis
2010
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Responses to measles immunization in children infected with human immunodeficiency virus
1994
Risk factors for low birth weight: a review
2004 Standout
A Controlled Trial of Povidone–Iodine as Prophylaxis against Ophthalmia Neonatorum
1995
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
2006 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Injectable Paromomycin for Visceral Leishmaniasis in India
2007
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
Chlamydia trachomatis infection during pregnancy
1991
3. Visceral leishmaniasis
2001
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
2000
Measles Vaccination in HIV-Infected Children: Systematic Review and Meta-Analysis of Safety and Immunogenicity
2011
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Theories of reasoned action and planned behavior as models of condom use: A meta-analysis.
2001 Standout
Sexually transmitted diseases treatment guidelines
2003 Standout
Longitudinal study of young children in Kenya: Intestinal parasitic infection with special reference to Giardia lamblia, its prevalence, incidence and duration, and its association with diarrhoea and with other parasites
1991
Lower trypanosomatids in HIV/AIDS patients
2003
Efficacy of Neonatal Ocular Prophylaxis for the Prevention of Chlamydial and Gonococcal Conjunctivitis
1989
Control of Neglected Tropical Diseases
2007 Standout
Leishmaniasis
1999 Standout
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care
2001 Standout
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
2005
Antiamoebic drugs for treating amoebic colitis
2009
Interventions for treating trichomoniasis in women
2003
Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis
1994
Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence
2005
Treatment of Kala-Azar in Southern Sudan using a 17-Day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-Day Sodium Stibogluconate Monotherapy
2007
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis
2000
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Epidemiology of the Leishmaniases
1995
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
New Insights on Classification, Identification, and Clinical Relevance ofBlastocystisspp
2008 Standout
Corneal blindness: a global perspective.
2001 Standout
Epidemiology and control of trachoma: systematic review
2010
Treatment options for visceral leishmaniasis
2006
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Biocidal Activity of Nanocrystalline Silver Powders and Particles
2008
Surface modification of inorganic nanoparticles for development of organic–inorganic nanocomposites—A review
2013 Standout
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Advances in leishmaniasis
2005 Standout
Factors Predicting Zimbabwean Students' Intentions To Use Condoms
1992
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment
2010 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
2015 Standout
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin B-lipid complex
1998
Population-Based Hematologic and Immunologic Reference Values for a Healthy Ugandan Population
2004
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs
2005
The association of gonorrhoea and syphilis with premature birth and low birthweight.
1993
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex
1998
Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control
2006 Standout
Antimony Toxicity
2010
Drug Resistance in Leishmaniasis
2006 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
Epidemiology and control of gonococcal ophthalmia neonatorum.
1989
Works of H.O. Pamba being referenced
Increased Risk of Early Measles in Infants of Human Immunodeficiency Virus Type 1-Seropositive Mothers
1992
Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate
1990
Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi
2001
A new rural focus of cutaneous leishmaniasis caused by Leishmania tropica in Kenya
1992
THE PREVALENCE OF CHLAMYDIA TRACHOMATIS INFECTION AMONG MOTHERS OF CHILDREN WITH TRACHOMA
1990
Leishmania donovani Parasites in the Nasal Secretions, Tonsillopharyngeal Mucosa, and Urine Centrifugates of Visceral Leishmaniasis Patients in Kenya
1993
Prophylaxis of Gonococcal and Chlamydial Ophthalmia Neonatorum
1988
Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya
1990
Biochemical Characterization and Zymodeme Classification of Leishmania Isolates from Patients, Vectors, and Reservoir Hosts in Kenya
1992
Pathogenicity of Trichomonas hominis in Kenya.
1988
Treatment of symptomatic trichomoniasis among adult women using oral nitroimidazoles.
1992
A review of HIV-1 in Africa.
1989